...
首页> 外文期刊>Cureus. >DECAF versus CURB-65 to Foresee Mortality among Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
【24h】

DECAF versus CURB-65 to Foresee Mortality among Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

机译:Decaf与Curb-65预见到患者患有慢性阻塞性肺病的急性加剧的患者的死亡率

获取原文

摘要

Objective To compare the precision of DECAF (Dyspnea, Eosinopenia, Consolidation, Acidemia, Atrial Fibrillation) and CURB-65 scoring systems in prediction of mortality among patients presenting with an acute exacerbation of chronic obstructive pulmonary disease (COPD). Material and methods A prospective, cross-sectional study was done at the Department of Pulmonology, Jinnah Postgraduate Medical Centre, Karachi, Pakistan over a period of seven months,?May 2019 through November 2019. Previously diagnosed patients of COPD (for more than six months), of either sex, aged between 40 and 70 years admitted primarily with an exacerbation were included in the study by non-probability consecutive sampling. Patients with myocardial infarction, chronic kidney disease and malignancy were excluded. All relevant data including patients’ demography, history, examination, DECAF and CURB-65 scores and in-hospital mortality were recorded on a proforma and later analyzed by using SPSS, version 20.0 (IBM Corp., Armonk, NY). Receiver operating characteristic (ROC) curve was drawn for comparison of accuracy of both scoring systems in prediction of in-hospital mortality (based on area under the curve (AUC)). Results There were 34 (29.8%) in-hospital mortalities while 80 (70.2%) survivals. AUC?for DECAF score was 0.777 (0.673-0.881) and of CURB-65 was 0.715 (0.613-0.817) that reveals fair accuracy of the tests. Sensitivity of DECAF and CURB-65 scoring systems was almost similar i.e. 67.65% and 64.71% respectively, however DECAF was more specific than CURB-65 (86.25% compared to 68.75%, respectively). Conclusion The findings of our study suggest the use of a combination of scoring systems for prediction of in-hospital mortality in acute exacerbation of COPD based on appropriateness, access to facilities and clinician's preference.
机译:目的,比较患者患者慢性阻塞性肺病(COPD)急性加剧的患者预测死亡率预测死亡率(呼吸困难,嗜血腺癌,固结,酸血症,心房颤动)和抑制-65评分系统的精度。物质和方法在七个月内,在七个月内,在七个月内进行肺部,金纳研究生医疗中心,卡拉奇,巴基斯坦,2019年5月至2019年11月,患有七十五年的预期,横截面研究。以前诊断出COPD患者(超过六个几个月),两年龄段,均在40至70岁之间被录取,主要是通过不概率的连续抽样中的研究。患有心肌梗死,慢性肾病和恶性肿瘤的患者被排除在外。所有相关数据包括患者人口统计,历史,检查,溃疡和遏制 - 65分数以及院内死亡率都被记录在Proforma,后来通过使用SPSS,版本20.0(IBM Corp.,Armonk,NY)进行分析。被绘制了接收器操作特征(ROC)曲线,以比较了在医院内死亡率预测中的评分系统的准确性(基于曲线下的面积(AUC))。结果34(29.8%)的医院死亡人数,而80(70.2%)幸存者。 AUC?对于Decaf评分为0.777(0.673-0.881),Curb-65为0.715(0.613-0.817),揭示了测试的公平准确性。减去溃疡和Curb-65评分系统的敏感性几乎相似即67.65%和64.71%,然而Decaf比Curb-65更具特异性(86.25%,分别为68.75%)。结论我们的研究结果表明,在基于适当性,进入设施和临床医生的偏好,使用评分系统的结合预测COPD的急性加剧中的入院性死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号